International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13910850
Original Research Article
Serum Total Calcium and Calcium/Phosphorus Ratio in Primary Hypertension and Correlation with Disease Severity: A Case-Control Study
Published
Oct. 10, 2024
Abstract

Objectives: This study aimed to assess serum total calcium and calcium/phosphorus ratio in patients with primary hypertension and correlate these parameters with blood pressure. Methods: This prospective comparative study included 50 newly diagnosed primary hypertension patients and 50 age- and sex-matched normotensive controls. Serum calcium was measured using arsenazo III reagent and serum phosphorus using ammonium molybdate reagent. Additional investigations included CBC, RFT, LFT and abdominal ultrasound. Results: The mean age was 44.06±11.74 years and 54% were males. Mean serum calcium (8.7±0.5 vs 9.1±0.6 mg/dL) and phosphorus (2.9±0.7 vs 3.5±0.4 mg/dL) were significantly lower, while calcium-phosphorus ratio was significantly higher (3.20±0.73 vs 2.63±0.30) in cases vs controls (p<0.05). Serum calcium negatively correlated (r=-0.391) and calcium-phosphorus ratio positively correlated (r=0.530) with blood pressure (p<0.05). Conclusion: Serum calcium and calcium-phosphorus ratio show significant alterations in primary hypertension, correlating with blood pressure severity. Monitoring and managing these parameters may be considered in hypertension management.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
2787 Views
368 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved